SCHEMBL4757394

SCHEMBL4757394

CS(=O)(=O)Nc1csc(NC(=O)c2ccccc2O)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.64
RAB9A P51151 10/20 0.64
HTT P42858 5/20 0.64
TP53 P04637 4/20 0.64
HSD17B10 Q99714 4/20 0.64
KDM4E B2RXH2 4/20 0.64
HPGD P15428 3/20 0.64
GAA P10253 2/20 0.64
ALDH1A1 P00352 2/20 0.64
RCE1 Q9Y256 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
MEN1 O00255 7/20 0.60
KMT2A Q03164 7/20 0.60
RXFP1 Q9HBX9 1/20 0.51
MAPK1 P28482 2/20 0.45
LMNA P02545 4/20 0.42
STAT3 P40763 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757398 0.83 SORT1 (0.51) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL703934 0.82 NPC1 (0.67) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL12974329 0.79 NPC1 (0.63) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL16256827 0.79 NPC1 (1.00) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL12974328 0.78 NPC1 (0.64) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL4757512 0.77 NPC1 (0.40) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL4757488 0.77 SLC2A1 (0.41) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL12994107 0.77 NPC1 (0.63) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL2696505 0.76 NPC1 (0.66) NPC1RAB9AHTTTP53HSD17B10
SCHEMBL29683064 0.76 NPC1 (0.70) NPC1RAB9AHTTTP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885HTT 1888/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885HTT 1888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.